Immunitrack’s CEO Stephan Thorgrimsen and chairman Karin Absalonsen will be participating in the LSX World Congress in London to connect with life science executives and investors.
About the LSX World Congress
The 9th LSX World Congress is the leading partnering, strategy, and investment event in Europe, with qualified 1:1 partnering at its core. The event brings together the CEOs and senior decision-makers from the world’s most innovative biopharma, med-tech, and health-tech companies with investors, senior BD&L teams, R&D leaders, and industry KOLs. Together they aim to create the world’s future medicines and improve patient outcomes. The congress represents the breadth, depth, and convergence of cutting-edge research and technology driving advances in the healthcare industry.